FIT HON TENG(06088.HK)及FITSingapore與夏普及Kantatsu訂立和解協議
格隆匯12月17日丨FIT HON TENG(06088.HK)發佈公吿,於2021年12月17日,公司及FITSingapore與夏普及Kantatsu訂立和解協議,據此,(i)訴訟將被撤銷;(ii)夏普將向FIT Singapore支付代價2400萬美元;及(iii)公司及FIT Singapore同意向夏普轉讓轉讓股份(即若干Kantatsu股份,按悉數轉換基準計算佔Kantatsu全部股權的約28.36%)。
為實現良好的企業管治及保護股東利益,根據公司對繼續進行訴訟所需的時間、成本及精力作出的評估,董事會認為和解將使集團得到適當的補償。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.